Specifically, overexpression of Aurora A mRNA in neuroblastoma tumor tissue was shown to be associated with high-risk disease, higher stage, unfavorable histology, MYCN amplification (p = 0.017), disease relapse (p = 0.019), and decreased progression-free survival [16]. This evidence concerns the gene MYCN and neuroblastoma.